How best to help people stop smoking?

The dangers of smoking are widely recognised, but what interventions work best to help people quit this deadly habit? EU-funded researchers are assessing a range of existing approaches and new cessation treatments. The results will inform public health policy in Europe and the wider world.

Countries
Countries
  Algeria
  Argentina
  Australia
  Austria
  Bangladesh
  Belarus
  Belgium
  Benin
  Bolivia
  Brazil
  Bulgaria
  Burkina Faso
  Cambodia
  Cameroon
  Canada
  Cape Verde
  Chile
  China
  Colombia
  Costa Rica
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Ecuador
  Egypt
  Estonia
  Ethiopia
  Faroe Islands
  Finland
  France
  French Polynesia
  Georgia

Countries
Countries
  Algeria
  Argentina
  Australia
  Austria
  Bangladesh
  Belarus
  Belgium
  Benin
  Bolivia
  Brazil
  Bulgaria
  Burkina Faso
  Cambodia
  Cameroon
  Canada
  Cape Verde
  Chile
  China
  Colombia
  Costa Rica
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Ecuador
  Egypt
  Estonia
  Ethiopia
  Faroe Islands
  Finland
  France
  French Polynesia
  Georgia


 

Published: 5 June 2018  
Related theme(s) and subtheme(s)
Health & life sciencesAllergy & asthma  |  Medical research  |  Molecular biology  |  Public health
Research policyOpen innovation
Countries involved in the project described in the article
Bulgaria  |  Cyprus  |  Greece  |  Italy  |  Serbia  |  Spain  |  Taiwan  |  United Kingdom
Add to PDF "basket"

How best to help people stop smoking?

Image

© Andrey Popov #187868473, 2018. Source: fotolia.com

SmokeFreeBrain brings together experts in toxicology, pulmonary medicine, neuroscience, and behavioural therapy, as well as health economics and health informatics. They are examining the effectiveness of anti-smoking strategies aimed at high-risk groups in high-middle-income countries, such as unemployed adults, people with chronic pulmonary disease and asthma patients – as well as the general population in lower-middle-income countries.

>“Smoking is the largest avoidable cause of lung diseases, morbidity and premature mortality worldwide,” says project coordinator Panagiotis Bamidis. “The purpose of our project is to deliver new knowledge regarding the cost-effectiveness of innovative smoking cessation interventions. This approach should improve the efficiency of public policy strategies aiming to reduce smoker numbers and therefore help to prevent lung diseases.”

Broad approach

The project is evaluating the effectiveness of public health service announcements which seek to encourage people to quit. It is also looking into the use of electronic cigarettes, both with and without nicotine. In addition, researchers have designed a specific neuro-feedback intervention protocol to combat addiction. The use of social media, mobile apps and text messaging (collectively named So-Lo-Mo) to help people stop is also being assessed, as is the value of drug-based approaches to curb tobacco cravings.

SmokeFreeBrain, which is scheduled to finish its work in October 2018, is currently piloting a number of interventions based in hospitals and laboratories in eight different countries – Bulgaria, Greece, Spain, Italy, Cyprus, Serbia, the United Kingdom and Taiwan.

More than 500 people are participating in these interventions across Europe and Taiwan. The smokers are being assessed over a year, with the aim of producing solid, quantifiable data about the effectiveness of the different approaches.

For example, the So-Lo-Mo approach is being tested in Spain and Taiwan and includes the development of mobile games and applications to encourage people to stop smoking. The drug interventions are being piloted in Spain, Serbia and Greece, while the use of e-cigarettes as a smoking cessation aid is being assessed in the United Kingdom.

Meanwhile, preliminary results show that the neuro-feedback intervention protocol can cause lasting changes in the brain cortex as people try to stop smoking.

Informing policy

“Dissemination and exploitation activities are key to the success of SmokeFreeBrain, as they will engage stakeholders while spreading the knowledge and experience gained in the project – maximising its benefit for the European economy and society,” explains Bamidis. “The results and the outputs of the project will target the research community as well as smoking cessation clinics and policymakers.”

>In addition, the project aims to transform its experiences and results into real policy actions. The goal is to shape clinical treatment and policy advice that favours scientifically evaluated and economically cost-efficient interventions.

Project details

  • Project acronym: SmokeFreeBrain
  • Participants: Greece (Coordinator), Bulgaria, Cyprus, Spain, Italy, United Kingdom, Serbia, Taiwan
  • Project N°: 681120
  • Total costs: € 3 187 865
  • EU contribution: € 2 981 001
  • Duration: November 2015 to October 2018

See also

 

Convert article(s) to PDF

No article selected


loading


Search articles

Notes:
To restrict search results to articles in the Information Centre, i.e. this site, use this search box rather than the one at the top of the page.

After searching, you can expand the results to include the whole Research and Innovation web site, or another section of it, or all Europa, afterwards without searching again.

Please note that new content may take a few days to be indexed by the search engine and therefore to appear in the results.

Print Version
Share this article
See also
Project website
Project details